GSK in line for $500m after end of Covid vaccine patent dispute
- Posted on August 8, 2025
- By The Times
- 1 Views
GSK in line for $500m after end of Covid vaccine patent dispute
British pharmaceutical group and Germany’s CureVac reach settlement with Pfizer and its partner BioNTech over mRNA vaccine technology
